NK cell expansion uses soluble B7-H6, 4-1BBL, and ICAM-1 polypeptides to drive proliferation without feeder cells.
Immune tolerogenic dendritic cells differentiate via citrullinated vimentin exposure to modulate immune responses.
Extracellular matrix and Rho-kinase inhibitor prevent centrifuge tension, reducing differentiation time by 33%.
Roll pressing mixed powder creates peptone-free granules that eliminate dust hazards while preserving heat-sensitive components.
Nucleic acid aptamers replace costly protein production by binding the HGF receptor to control c-Met activity.
Lower molecular weight poloxamer composition reduces shear stress, resolving lot-to-lot variability and improving cell viability consistency.
Peripheral covalent crosslinking to multi-armed polymers prevents dissolution in phosphate buffered saline, ensuring long-term stability.
Sendai virus vectors deliver reprogramming factors to generate stable pluripotent stem cells.
Specific peptide sequences replace animal-derived extracts in culture media to ensure stable quality and safety while promoting cell growth.
Engineered oleosins bind excess nitrogen to prevent microbial denitrification, reducing soil nitrous oxide emissions by up to 95%.
Serum withdrawal culture enriches clonogenic mesenchymal stem cells, resolving low yield and long isolation times.
Stevioside and methyl jasmonate induce viniferin synthesis in grape tree callus cultures, resolving mass production bottlenecks for pharmaceutical applications.
IαI protein coatings replace animal-derived components to eliminate contamination risks while maintaining pluripotency and long-term culture stability.
Pre-activation with CD3 signal activators and RetroNectin-coated beads maintains the undifferentiated state of T cells during gene modification.